-+ 0.00%
-+ 0.00%
-+ 0.00%

KALARIS THERAPEUTICS INC - TH103 GENERALLY WELL TOLERATED, SUPPORTING FURTHER DOSE ESCALATION

Reuters·12/17/2025 21:01:11

Please log in to view news